Chapter LXXII: Egészségbiztosítási Alap (Health Insurance Fund)

Overview

This chapter is the Egészségbiztosítási Alap (Health Insurance Fund) — one of the two large extra-budgetary social-insurance funds of the Hungarian state, alongside the Pension Fund. It is not a ministry and not an agency; it is the financing pool through which compulsory contributions and earmarked taxes are collected and through which the cash and in-kind health entitlements of the insured population are paid. The 2026 plan is balanced by construction: 4,945,568.6 millió Ft of expenditure against 4,945,568.6 millió Ft of revenue, a zero balance. The capital (felhalmozási) side is a single 226.0 millió Ft investment line, financed by an equal transfer; the entire substance of the chapter is on the operating side.

The envelope is one of the largest in the budget. It divides into four blocks that behave very differently under the analytical frame:

• Cash benefits (1,338,998.1 millió Ft, 27.1% of the chapter) — earnings- replacement transfers: csecsemőgondozási díj, táppénz, gyermekgondozási díj, the rokkantsági/rehabilitációs ellátások, and two minor lines.
• Gyógyító-megelőző ellátás — curative and preventive care purchasing (2,886,835.2 millió Ft, 58.4%) — the money that flows to GPs, hospitals, outpatient clinics, ambulance services, dialysis, and the high-cost drug programme.
• Other care and pharmaceutical support (710,846.7 millió Ft, 14.4%) — the gyógyszertámogatás (drug subsidy), medical-device subsidy, travel reimbursement, and several smaller settlement lines.
• Administration (9,262.6 millió Ft operating + 226.0 millió Ft capital, 0.2%) — the running cost of the central organ that administers the Fund.

A note on what the lens does not do here. The classical-liberal frame is a test of state financing arrangements — whether a function should be funded by compulsory contribution, and through what mechanism. It is not a claim that curative medicine is unimportant; it plainly is not. Hungary spends roughly 6.5% of GDP on health against an OECD average of about 9.3%, and per-capita health spending of about USD 3,303 PPP against an OECD average near USD 5,967 PPP¹ — the binding problem in Hungarian healthcare is under-resourcing and a state-monopoly delivery model that produces queues, not over-spending. The analysis below treats almost the entire curative block as Keep on rights- protection grounds, and concentrates the reform argument on the financing architecture of the earnings-replacement cash benefits, where the framework has a sharp and specific objection that has nothing to do with whether the benefits are generous enough.

Expenditure Analysis

Csecsemőgondozási díj (Infant-Care Benefit, CSED)

• Current allocation: 182,603.8 millió Ft

• Classification: Phase-Out (25 years)

• Rationale: CSED replaces income for a parent during the first 168 calendar days after a birth. It is paid at 100% of the prior daily income (70% where the parent returns to paid work after the child’s first three months).² This is the structural feature that the analytical frame fastens on, and it is worth being exact about it. CSED is not a flat per-child grant. It is an earnings-replacement transfer: the benefit a recipient draws is a fixed multiple of what that recipient earned before the birth. The funding, by contrast, is pooled — it comes from the szociális hozzájárulási adó and the társadalombiztosítási járulék paid by every contributor into the Fund, at a flat rate on wages.

  Set those two facts beside each other. A parent who earned at the top of the wage distribution before the birth draws a CSED several times larger, per day, than a parent who earned at the minimum wage — for the same event, the same 168 days, the same biological fact of a new child. The contribution that funds both is levied at the same flat rate on every insured wage. The effect is a transfer that runs, in net terms, within the working population from lower earners to higher earners: the minimum-wage contributor is part-funding the supplement that scales with the salary of the upper-decile contributor. The universalist branding — “every insured parent is covered” — is true and hides this. Coverage is universal; the benefit amount is earnings-scaled, and an earnings-scaled benefit paid out of a flat-rate pooled levy is a regressive cross-subsidy whatever it is called.

  The reform is not to abolish income protection around a birth. It is to change the financing mechanism so that the benefit a parent draws is funded by that parent’s own prior contributions rather than by a pooled levy that makes lower earners cross-subsidise higher earners. A funded individual social-insurance account — each worker accumulates a balance from their own contributions, draws their own earnings-replacement benefit from it, with a general-revenue floor for workers whose balances are thin — preserves the income-protection function and removes the within-class transfer. The insured person still receives an earnings-related benefit; it is simply their own earnings that fund it.

• Transition mechanism: Funded individual social-insurance accounts. The protected parties are every current claimant and every worker who has contributed under the present pooled rules in the expectation of pooled cover; their accrued position is honoured in full. New labour-market entrants begin accumulating in individual accounts; existing contributors retain pooled cover, financed from general revenue, with the pooled cost declining as the contributor base ages out and is replaced by account- holders. A minimum benefit floor, general-revenue financed, covers parents whose individual balances are insufficient; the floor’s cost falls as account balances mature. The horizon is set by contributor turnover, not by policy preference — a full working-life cohort replacement is roughly 25 years, and that is the schedule. This is a hybrid-pillars transition: the legacy pooled pillar runs down as the funded pillar fills.

• Affected groups: No current recipient loses anything. The party that “loses” is a future upper-decile earner who, under the present pooling, receives a benefit part-funded by lower earners; under the reform that earner funds their own benefit. Lower-earning contributors gain — they stop cross-subsidising and, with a general-revenue floor, retain protection.

Táppénz (Sick Pay)

• Current allocation: 266,560.8 millió Ft
• Classification: Phase-Out (25 years)
• Rationale: Táppénz replaces wages during sickness absence, at 60% of the contribution base (50% for workers with shorter insurance histories or in the early days of an absence). In 2024 Hungarian workers claimed approximately 26 million calendar days of sick benefit nationally.³ The structural objection is identical to CSED’s: this is an earnings-replacement benefit — the daily payment scales with the claimant’s prior wage — financed from a flat-rate pooled levy. A higher earner’s sick day is reimbursed at a higher daily rate than a lower earner’s, out of contributions levied at the same rate on both. The pooled-levy-funding-an-earnings-scaled-benefit pattern produces the same within-class cross-subsidy: the diagnostic is earnings-scaled benefit plus flat-rate pooled funding plus universalist branding, and táppénz exhibits all three.
• Transition mechanism: Mirrors CSED — funded individual sickness accounts, existing claims and accrued contributor positions fully honoured, a general-revenue minimum floor during the transition, 25-year horizon set by contributor turnover. The structurally relevant distinction from CSED is the much shorter average claim: a sickness absence is measured in days or weeks, not in months around a birth. A shorter, more frequent draw means the account balance a worker needs in order to self-insure the benefit floor accumulates faster relative to the benefit drawn, so practical convergence runs ahead of the nominal 25-year envelope. Individual accumulation accounts with a solidarity-fund floor are not a hypothetical design: Chile operates exactly this structure for unemployment insurance under the Cuenta Individual de Cesantía, established by Law 19,728 of 2001 — each worker accumulates an individual balance, with a defined benefit floor financed from a separate solidarity fund.⁴ The mechanism transfers cleanly to sickness insurance.
• Affected groups: As CSED. No current claimant is affected. The cross-subsidy that ends ran from lower earners to higher earners.

Egyszeri segély (One-Off Assistance)

• Current allocation: 450.0 millió Ft
• Classification: Nominal Freeze
• Rationale: A small discretionary one-off assistance line within the cash-benefit block. At 450.0 millió Ft it is immaterial to the chapter total and the cost of separately reforming it would exceed any saving. It is not an earnings-scaled entitlement and does not carry the structural defect of the three large cash lines. Hold it at nominal level; real-terms erosion at typical inflation does the bounded work.
• Transition mechanism: None. Allocation held flat in nominal terms.
• Affected groups: Recipients of the discretionary one-off payments; no displacement under a freeze.

Kártérítési és baleseti járadék (Compensation and Accident Annuity)

• Current allocation: 12,529.2 millió Ft
• Classification: Keep
• Rationale: This line pays annuities for occupational accident and injury compensation. These are not discretionary transfers and not earnings-scaled social benefits in the CSED/táppénz sense; they are compensation owed for involuntary injury sustained, in most cases, in the course of insured employment — accrued, individualised claims with the character of a liability the Fund has incurred rather than a programme it chooses to run. Honouring an accrued compensation claim is the rule-of-law position the framework takes throughout. Keep.
• Transition mechanism: None. Accrued claims are paid as they fall due.
• Affected groups: Recipients of accident and injury annuities. Keep protects them.

Gyermekgondozási díj és örökbefogadói díj (Child-Care Benefit and Adoption Benefit, GYED)

• Current allocation: 457,002.0 millió Ft

• Classification: Phase-Out (25 years)

• Rationale: GYED is the largest single cash line in the chapter — larger than táppénz, larger than the rokkantsági block — and it carries the earnings-replacement defect in its sharpest form. The benefit is set at 70% of the parent’s prior gross income, subject to a statutory ceiling; from 1 January 2026 the maximum monthly amount is a gross 451,920 Ft.⁵ It is drawn for an extended period — up to the child’s second birthday — which makes it the largest per-recipient liability of the three earnings-scaled lines.

  The multi-tier arithmetic makes the within-class transfer concrete. A parent who earned the minimum wage before the birth draws GYED at 70% of that minimum wage. A parent who earned at or above the ceiling draws the capped maximum — a gross 451,920 Ft a month. The two benefits differ by a wide multiple, per month, for the full run to the child’s second birthday. Both are funded from the same flat-rate contribution levied on every insured wage, including the minimum-wage parent’s. The minimum-wage contributor is funding, in part, the supplement that scales with the ceiling-level earner’s salary. The universalist framing — “GYED supports every working parent” — describes the coverage and conceals the distribution: coverage is universal, the benefit is earnings-scaled, and an earnings-scaled benefit paid from a flat pooled levy transfers, on net, from lower earners to higher earners.

  This is the same financing pathology that runs through the supplementary pension supplement, the family tax credit, and every other line where a benefit scales with prior earnings while the funding is pooled — and it is worth naming the mechanism plainly because mainstream discourse, governing and opposition alike, debates GYED as a question of generosity (is the ceiling high enough, is the duration long enough) and almost never as a question of who funds whom. The reform answers the second question: fund the benefit from the recipient’s own prior contributions, and the regressive cross-subsidy disappears without the income-protection function being touched.

• Transition mechanism: Hybrid-pillars, mirroring CSED — funded individual accounts for new entrants, pooled cover retained and general-revenue financed for existing contributors, a minimum floor for thin balances, 25-year horizon set by contributor turnover. The distinguishing feature of GYED is the long draw period (to the child’s second birthday), which makes it the line whose account balances must be deepest and therefore the line whose practical convergence is closest to the full nominal 25-year envelope.

• Affected groups: No current GYED recipient is affected; every accrued and in-payment claim is honoured. The cross-subsidy that ends ran from minimum-wage and lower-decile contributors to ceiling-level earners.

Rokkantsági, rehabilitációs ellátások (Disability and Rehabilitation Benefits)

• Current allocation: 419,852.3 millió Ft

• Classification: Keep

• Rationale: This line funds the benefits paid to people with reduced working capacity — the rokkantsági ellátás for those assessed as unable to work and the rehabilitációs ellátás for those assessed as rehabilitable. It is a large line, reaching on the order of 254,000 people following the 2024 reassessment of the qualification rules.⁶ It is tempting, given the earnings-replacement objection applied to CSED, táppénz and GYED, to reach for the same classification here. That would be a mistake, and the distinction matters.

  The three cash lines above replace income during a temporary, foreseeable, and in most cases voluntary or quasi-voluntary life event — a birth, a short illness, early child-rearing — for which a working person can, in principle, accumulate a funded reserve over a career. Disability is none of those things. It is an involuntary, often permanent, and frequently early-onset loss of earning capacity. A worker disabled at thirty has not had a working life over which to accumulate a self-insurance balance; the funded-account logic that fits a birth or a sick week does not fit a permanent loss of the capacity to earn at all. The framework’s protective category — a response to involuntary harm whose magnitude makes it a matter of rights rather than preference — is the correct home for this line. Disability support of last resort, for people who cannot self-insure against a risk that may strike before they have earned anything, is within the class of functions the classical-liberal frame affirms. Keep.

  Keep does not mean immune from review. The assessment process — who is classified as rokkant, who as rehabilitable, on what evidentiary standard — is a genuine governance question, and the disability rolls of many European states have at times absorbed people who, with the right rehabilitation pathway, could re-enter work. But that is a question of assessment integrity and rehabilitation design, addressed by the qualification rules and the rehabilitation service, not by phasing out the benefit. The line is Keep.

• Transition mechanism: None. The benefit is retained. Assessment-rule and rehabilitation-pathway review is ordinary governance, separate from classification.

• Affected groups: People with reduced working capacity drawing disability and rehabilitation benefits. Keep protects them.

Gyógyító-megelőző ellátás — curative and preventive care (consolidated)

• Current allocation: 2,886,835.2 millió Ft (sum of the alcím-7 sub-lines and the associated céltartalék and supplementary-financing lines)

• Classification: Keep

• Rationale: This is the financing of medical care itself, and it is the largest block in the chapter. It comprises, by sub-line: háziorvosi és háziorvosi ügyeleti ellátás (GP and GP out-of-hours care, 296,534.0 millió Ft); védőnői szolgáltatás (health-visitor service, 27,283.3); fogászati ellátás (dental care, 86,612.2); otthoni szakápolás (home nursing, 12,980.8); betegszállítás (patient transport, 12,852.3); művesekezelés (dialysis, 38,771.1); célelőirányzatok (earmarked allocations, 974,641.9); mentés (ambulance service, 45,781.5); laboratóriumi ellátás (laboratory services, 30,295.6); járóbeteg-szakellátás (outpatient specialist care, 221,118.0); népegészségügy fejlesztése (public-health development, 2,717.5); többletkapacitás-befogadás (capacity-admission reserve, 4,000.0); működési költségelőleg (operating advance, 2,000.0); molekuláris diagnosztikai (PCR) ellátás (10,802.1); fekvőbeteg-szakellátás (inpatient specialist care, 762,602.0); extrafinanszírozás (1,000.0); speciális finanszírozású szakellátás (specially-financed care, 74,382.8); gyógyító-megelőző ellátás céltartalék (curative-preventive reserve, 7,460.1); egészségügyi szolgáltatók kiegészítő finanszírozása (provider supplementary financing, 80,000.0); and nagyértékű gyógyszerfinanszírozás (high-cost drug financing, 195,000.0).

  These lines purchase rights-relevant medical care: emergency treatment, inpatient and outpatient specialist care, primary care, dialysis for renal failure, the high-cost drug programme that finances oncology and rare-disease therapies. Acute and emergency medicine is a protective response to involuntary, irreversible harm — a person in renal failure or needing emergency surgery is not a consumer weighing a subjective preference, and rationing that care by ability to pay at the point of need is precisely the outcome the framework’s protective category exists to prevent. Classified Keep as a block.

  Keep is a statement about whether the function is financed, not an endorsement of how it is delivered, and the distinction is the substantive point in this chapter. Hungary finances its health system through a single state purchaser, NEAK, paying overwhelmingly state-owned providers. A single state purchaser facing state-owned providers has no market price signal for the cost, mix, or quality of care: NEAK sets tariffs administratively, capacity is allocated administratively, and the soft budget constraint characteristic of state-owned providers — losses absorbed by the centre rather than disciplining the provider — runs through the whole system. The visible symptom is the one every Hungarian household already knows: long waits in the state system, and a parallel private sector that exists precisely because the state monopoly fails on access and timeliness. Roughly a quarter of total health spending in Hungary is already out-of-pocket — well above the EU norm — and voluntary insurance and private clinics (Medicover, Affidea, Doktor24 and others) operate at scale, delivering same-week appointments against months in the state queue.¹ The parallel private sector is the in-country demonstration that competing providers and visible prices produce faster access; Hungarian readers do not need a foreign example, because they already use one.

  The reform direction this chapter points at is therefore not a cut to the curative envelope — the envelope is, if anything, low for the country’s needs — but a change in the purchasing architecture: separating the financing function (which stays) from state ownership of providers (which need not), allowing provider plurality so that the purchaser has a real choice and a real price, and unbundling routine care from catastrophic care so that price discovery can operate where it can and pooled protection operates where it must. That is delivery-model reform, not a transition- taxonomy reclassification, and it belongs in the whitepaper’s healthcare treatment rather than in a line-item phase-out. The classification of the financing line is Keep.

• Transition mechanism: None at the level of the financing line. Delivery- model reform — provider plurality, purchaser-provider separation, price discovery on routine care — is a structural programme addressed at system level, not a phase-out of this allocation.

• Affected groups: Every insured person who uses the state health system. Keep protects the financing; delivery reform aims to improve what they receive for it.

Gyógyfürdő és egyéb gyógyászati ellátás támogatása (Spa and Other Balneological-Treatment Subsidy)

• Current allocation: 2,514.2 millió Ft

• Classification: Phase-Out (5 years)

• Rationale: This line subsidises balneological and spa treatments. It sits apart from the curative block in character: where emergency surgery and dialysis are protective responses to irreversible harm, spa therapy is at the discretionary, quality-of-life end of the spectrum, and its medical cost-effectiveness against alternatives is exactly the kind of contested, preference-laden allocation a state purchaser cannot price. There is, in addition, an established commercial market in Hungarian spa and wellness provision; the subsidised treatments compete with services consumers already buy voluntarily at a market price. The case for compulsory-contribution financing of this line is weak — it is neither rights-protection nor a response to involuntary harm — and the honest classification is a phase-out.

  The protected party here is not a claimant of an earnings-replacement entitlement; it is the set of spa operators delivering subsidised treatment under current arrangements, and the patients mid-course of a prescribed programme. A short linear phase-out gives operators time to re-price their offering toward the voluntary market they already serve and gives in-flight patients time to complete prescribed courses. Five years is sufficient: this is a discrete, small, commercially-substitutable subsidy, not a cohort entitlement.

• Transition mechanism: Linear five-year phase-out. The subsidy declines in equal annual steps to zero; spa operators transition the subsidised volume onto the existing voluntary-pay market over the window; patients on a prescribed course at the point of reform complete it under run-off.

• Affected groups: Spa and balneological operators dependent on the subsidy, who face a re-pricing toward voluntary demand; patients who currently receive subsidised treatment, who would pay the market price after the window or seek the treatment as the discretionary purchase it is.

Anyatej-ellátás (Breast-Milk Supply)

• Current allocation: 200.0 millió Ft
• Classification: Keep
• Rationale: This line finances the supply of donor breast milk, in practice for premature and medically vulnerable infants who cannot otherwise be fed. At 200.0 millió Ft it is the smallest substantive line in the chapter. It is a protective response to involuntary harm to identifiable vulnerable individuals — newborns in neonatal care — with no voluntary alternative available to the infant. Keep.
• Transition mechanism: None.
• Affected groups: Premature and medically vulnerable infants and their families. Keep protects them.

Gyógyszertámogatás — drug subsidy (consolidated)

• Current allocation: 566,862.5 millió Ft (gyógyszertámogatás kiadásai 434,423.3 millió Ft plus gyógyszertámogatási céltartalék 132,439.2 millió Ft)

• Classification: Keep

• Rationale: This is the reimbursement of prescription medicines for insured patients — the support that brings chronic-disease and acute medication within reach at the pharmacy counter. NEAK reimburses at tiered rates depending on the therapeutic category and the severity of the indication, with the higher state-paid shares attaching to the more chronic and severe conditions.⁷ The severity-graduated structure is itself evidence that the line is functioning as protection against involuntary harm rather than as a discretionary consumption subsidy: the state-paid share rises precisely where the patient’s need is least a matter of preference and most a matter of medical necessity. Reimbursement of medicines for serious and chronic illness is within the protective category. Keep.

  This is a Keep with a real efficiency caveat, and the caveat is large enough to name. A single state purchaser negotiating a positive list and administratively-set reimbursement tiers has no market price signal for the relative value of competing therapies; the list and the tiers are set by administrative judgement, and the manufacturer-and-distributor payments that appear on the revenue side of this same chapter (see below) are the state’s attempt to claw back, through a levy, rents that the administered-pricing system itself creates. The financing of the line is Keep; the pricing mechanism is open to the ordinary value-for-money scrutiny that Keep always permits.

• Transition mechanism: None. Financing retained; positive-list and reimbursement-tier design open to efficiency review.

• Affected groups: Insured patients on subsidised prescription medication, particularly the chronically and seriously ill. Keep protects them.

Gyógyászati segédeszköz támogatás — medical-device subsidy (consolidated)

• Current allocation: 81,525.1 millió Ft (egyéb gyógyászati segédeszköz 64,558.1 millió Ft plus egyedi készítésű gyógyászati segédeszköz 16,967.0 millió Ft)
• Classification: Keep
• Rationale: Subsidy of medical aids and devices — prosthetics, mobility aids, custom-made appliances — for insured patients. The custom-made line in particular serves people whose medical need cannot be met by an off-the-shelf product. Like the drug subsidy, this is support for the management of involuntary medical conditions rather than a discretionary consumption transfer. Keep, with the same standard caveat that the procurement and reimbursement pricing of devices is open to value-for-money review.
• Transition mechanism: None.
• Affected groups: Insured patients dependent on prosthetics, mobility aids, and custom appliances. Keep protects them.

Utazási költségtérítés (Travel Cost Reimbursement)

• Current allocation: 6,161.3 millió Ft
• Classification: Keep
• Rationale: Reimbursement of patients’ travel costs to receive care. This is an access-supporting adjunct to the curative function: where the care itself is Keep, the cost of physically reaching it — for patients in rural areas or those needing care concentrated in specialist centres — is part of making the rights-relevant service genuinely available rather than nominally available. It moves with the curative block. Keep.
• Transition mechanism: None.
• Affected groups: Patients, particularly rural and those referred to distant specialist centres, who rely on travel reimbursement to access care.

Nemzetközi egyezményből eredő és külföldön történő ellátások (Cross-Border and Treaty-Based Care)

• Current allocation: 30,365.2 millió Ft (sürgősségi ellátás 27,039.2 millió Ft; külföldön tervezett ellátások megtérítése 106.0; külföldön speciális ellátások 3,220.0)
• Classification: Keep
• Rationale: These lines fund emergency and planned care for insured Hungarians abroad and the settlement of treaty-based reciprocal-care obligations (chiefly the EU’s cross-border-care framework). The sürgősségi ellátás component is emergency care — a protective response to involuntary, time-critical harm that happens not to occur on Hungarian soil. The treaty-settlement components are obligations Hungary has contracted and which bind while the treaty binds; honouring a contracted reciprocal obligation is the rule-of-law method the framework requires. Keep.
• Transition mechanism: None. Treaty obligations are honoured on their terms; emergency cover abroad is retained.
• Affected groups: Insured Hungarians who fall ill or are injured abroad; counterpart states under reciprocal-care treaties.

Természetbeni ellátások céltartaléka (In-Kind Benefits Reserve)

• Current allocation: 3,000.0 millió Ft
• Classification: Keep
• Rationale: A contingency reserve against in-kind benefit cost overruns within the curative block. A reserve takes the classification of the function it backstops; it backstops Keep curative lines, and prudent provisioning against an estimation error in a rights-relevant block is ordinary fiscal management. Keep.
• Transition mechanism: None.
• Affected groups: None directly; the reserve backstops the curative block.

Egyéb, ellátásokhoz kapcsolódó kiadások (Other Benefit-Related Costs)

• Current allocation: 11,418.4 millió Ft (kifizetőhelyeket megillető költségtérítés 6,178.7 millió Ft; postaköltség 5,004.5; egyéb kiadások 235.2)
• Classification: Keep
• Rationale: The mechanical settlement costs of paying the Fund’s benefits — reimbursement of employers who act as paying agents (kifizetőhely), postage on benefit payments, and residual minor costs. These are not a programme; they are the unavoidable transaction cost of operating the benefit lines, and they rise and fall with those lines. They follow the classification of the benefits they service — predominantly Keep lines — and cannot be cut independently of the function. Keep, on the same logic by which a payroll charge follows its personnel line.
• Transition mechanism: None. Moves with the benefit lines.
• Affected groups: None.

Gyógyszertárak juttatása és szolgáltatási díja (Pharmacy Remuneration and Service Fee)

• Current allocation: 8,800.0 millió Ft
• Classification: Keep
• Rationale: The service fee paid to pharmacies for dispensing subsidised medicines — the remuneration of the dispensing function that delivers the gyógyszertámogatás line to patients. It is the transaction cost of the drug- subsidy function and follows that function’s Keep classification; it cannot be removed without removing the means by which subsidised medicine reaches the patient. Keep, with pharmacy remuneration formulae open to the standard efficiency review.
• Transition mechanism: None. Moves with the drug-subsidy function.
• Affected groups: Pharmacies dispensing subsidised medicines; insured patients who collect them.

Vagyongazdálkodás (Asset Management)

• Current allocation: 5.7 millió Ft expenditure (against 46.7 millió Ft of associated revenue)
• Classification: Keep
• Rationale: The asset-management line of the Fund — the cost of managing the Fund’s own property, against which it books a small property income. At 5.7 millió Ft of expenditure it is the smallest line in the chapter and immaterial to any total. It is the ordinary administrative cost of an insurance fund holding and managing assets; it generates more revenue than it costs. Keep.
• Transition mechanism: None.
• Affected groups: None.

Egészségbiztosítási költségvetési szervek — Központi hivatali szerv (Administrative Organ of the Fund)

• Current allocation: 8,656.9 millió Ft operating (személyi juttatások 5,960.8 millió Ft; munkaadókat terhelő járulékok és szociális hozzájárulási adó 863.1; dologi kiadások 1,653.0; egyéb működési célú kiadások 180.0) plus 226.0 millió Ft capital (beruházások)

• Classification: Keep

• Rationale: This is the running cost of the central organ that administers the Health Insurance Fund — the body that collects contributions, maintains the insurance register, processes claims, and pays benefits. At 8,656.9 millió Ft of operating cost plus 226.0 millió Ft of capital, the administration of the entire 4,945,568.6 millió Ft Fund costs under 0.2% of the envelope it administers — an administrative ratio that is, by the standard of large transfer systems, lean.

  The classification of an administrative organ follows the classification of the function it administers. The Fund pays a mixture of Keep curative lines and Phase-Out earnings-replacement lines; some claims-processing, contribution-collection and register-keeping function is required whichever way the cash benefits are ultimately financed, because the curative block and the disability block remain and must be administered. The administrative organ is therefore Keep at the chapter level. If the cash-benefit financing transition runs its full course, the scale of the administrative function shifts — from administering pooled earnings-replacement benefits toward administering funded accounts and a curative purchaser — but the function does not disappear, and a 25-year transition gives ample time for the staffing mix to adjust through ordinary turnover. The employer-contribution sub-line (863.1 millió Ft) is, as in every institutional chapter, the state taxing its own administrative payroll — a transfer from the Fund’s pocket to the treasury’s pocket, real in the accounts but not a separately decidable cost. Keep.

• Transition mechanism: None at the chapter level. The administrative organ is retained; its functional mix shifts gradually if the cash-benefit financing reform proceeds, absorbed through ordinary staff turnover over the transition horizon.

• Affected groups: Staff of the administrative organ; no displacement — the function is retained and rescaled, not closed.

Revenue Items

The revenue side of this chapter is, unusually, almost as analytically substantial as the expenditure side, because the Health Insurance Fund is financed predominantly by earmarked compulsory contributions rather than by fees. The chapter balances exactly: 4,945,568.6 millió Ft of revenue against 4,945,568.6 millió Ft of expenditure.

• Name: Társadalombiztosítási járulék E. Alapot megillető része és egészségbiztosítási járulék (Social-Insurance Contribution accruing to the Health Fund, plus the Health-Insurance Contribution)

• Current yield: 2,231,800.0 millió Ft

• Type: Tax (compulsory social-insurance contribution)

• Notes: The single largest revenue line in the chapter and the core financing of the Fund. The társadalombiztosítási járulék is the employee-side social-insurance contribution, levied at a flat 18.5% of the gross wage,⁸ of which a defined share is earmarked to the Health Fund. Its economic incidence falls on the worker: it is withheld from gross pay before take-home is calculated, and in incidence terms a payroll levy is borne by the employee regardless of which side of the payslip it is statutorily assigned to. This is the levy that funds the earnings-replacement cash benefits; the flat rate on every wage is precisely what makes the pooled funding of earnings-scaled benefits a regressive cross-subsidy. Its yield would not disappear under the cash-benefit reform — contributions would be redirected into the contributor’s own funded account rather than into the pool — but its character as a pooled levy would change.

• Name: Szociális hozzájárulási adó E. Alapot megillető része (Social Contribution Tax share accruing to the Health Fund)

• Current yield: 621,642.3 millió Ft

• Type: Tax (employer-side payroll tax)

• Notes: The portion of the szociális hozzájárulási adó (SzocHo) earmarked to the Health Fund. SzocHo is the employer-side payroll tax, levied at 13% of the gross wage.⁹ Its statutory burden is on the employer; its economic incidence is on the worker, through suppressed gross wages — the employer prices the total cost of employment, and the levy is paid out of the wage the worker would otherwise have received. SzocHo is the most distortionary of the major taxes funding this Fund: a tax on the act of employing labour, it widens the wedge between what an employer pays to employ a worker and what the worker takes home, suppressing both formal employment and take-home pay. Set the layers together for a Hungarian working household. On the payroll layer, SzocHo at 13% on the employer side, SZJA at a flat 15%, and the employee társadalombiztosítási járulék at 18.5% together mean that roughly 41 Ft of every 100 Ft of total employer cost reaches the state before the worker spends anything. On the consumption layer, ÁFA at 27% — the highest standard rate in the EU — captures a further 12 to 13 Ft of the original 100 when the remaining take-home is spent. On the excise layer, jövedéki adó adds 40 to 60% to the shelf or pump price of fuel, alcohol and tobacco. The cumulative effective state take from full employer compensation is in the 55 to 60% range for a typical Hungarian working household — not the visible payroll wedge alone. SzocHo is the first layer of that stack, and it is the layer that bears most directly on whether a job is created at all.

• Name: Egyéb járulékok és hozzájárulások (Other Contributions)

• Current yield: 123,500.0 millió Ft

• Type: Tax (compulsory contributions)

• Notes: Residual compulsory contributions earmarked to the Fund — including health-service contributions for those not in insured employment. Same incidence logic as the main contribution lines.

• Name: Költségvetési hozzájárulások — Járulék címen átvett pénzeszköz and Kiadások támogatására tervezett pénzeszköz-átvétel (Central-Budget Contributions)

• Current yield: 1,711,999.8 millió Ft (járulék címen átvett pénzeszköz 730,391.6 millió Ft; egészségügyi feladatok ellátásával kapcsolatos költségvetési hozzájárulás 981,608.2 millió Ft)

• Type: Other (transfer from the central budget)

• Notes: This is the second-largest revenue block and it is the honest measure of how far the Fund’s own contribution revenue falls short of its obligations: roughly 1.71 ezer milliárd Ft, more than a third of the chapter, is a transfer from the central budget to plug the gap between earmarked contributions and benefit spending. The “insurance fund” is, in cash terms, substantially general-revenue financed. This matters for the reform argument: it confirms that the present arrangement is not a closed actuarial system in which contributions match entitlements, but a pooled transfer system topped up from general taxation — which is exactly why the within-class cross- subsidy in the earnings-scaled benefits is not self-correcting.

• Name: Népegészségügyi termékadó (Public Health Product Tax, “chip tax”)

• Current yield: 96,900.0 millió Ft

• Type: Tax (excise on specified products)

• Notes: An earmarked tax on products with high sugar, salt or caffeine content — the so-called “chip tax” — levied on the producer or distributor and passed through to the consumer in the shelf price. Its incidence is on the consumer of the taxed products, and because consumption of the targeted products does not fall sharply with income, it is mildly regressive in incidence. It is a behaviourally-motivated tax presented as health policy; in fiscal terms it is a modest earmarked consumption tax. It is less distortionary than the payroll taxes — it falls on a discretionary consumption category rather than on the act of employment — and its yield is not contingent on the expenditure reforms proposed above.

• Name: Gyógyszergyártók és forgalmazók befizetései (Pharmaceutical Manufacturer and Distributor Payments)

• Current yield: 132,440.2 millió Ft (szerződések szerinti befizetések 41,446.3 millió Ft; folyamatos gyógyszerellátást biztosító befizetések 90,992.9; nagyértékű gyógyszerfinanszírozást biztosító befizetések 1.0; gyógyászati segédeszköz forgalmazással kapcsolatos bevételek 1.0)

• Type: Charge (sector-specific levies and contracted payments)

• Notes: Payments by drug manufacturers and distributors into the Fund — partly contracted clawback arrangements, partly a sector levy. Economically, this revenue is the mirror image of the gyógyszertámogatás expenditure: the state administers drug prices and reimbursement tiers, the administered system generates margin for manufacturers and distributors, and the state then levies part of that margin back. It is a clawback on rents the administered-pricing system itself creates. If the drug-pricing mechanism were reformed toward genuine price discovery, both this revenue line and the corresponding subsidy expenditure would shrink together; the levy is a symptom of administered pricing, not an independent revenue base.

• Name: Baleseti és egyéb kártérítési megtérítések (Accident and Compensation Recoveries)

• Current yield: 10,954.1 millió Ft

• Type: Fee / Charge (recoveries and reimbursements)

• Notes: Recovery of benefit costs from liable third parties — chiefly recoveries against those responsible for accidents whose victims the Fund has compensated. This is cost-recovery, not a tax; it offsets the kártérítési és baleseti járadék expenditure and would move with it.

• Name: Nemzetközi egyezményből eredő ellátások megtérítése (Treaty-Based Care Reimbursements)

• Current yield: 9,504.5 millió Ft

• Type: Other (reciprocal-care settlement receipts)

• Notes: Receipts from counterpart states under reciprocal cross-border care treaties — the revenue mirror of the treaty-based-care expenditure lines. Settlement income on contracted obligations; moves with that block.

• Name: Késedelmi pótlék, bírság (Late-Payment Surcharge and Penalty)

• Current yield: 5,900.0 millió Ft

• Type: Charge (penalty and interest on overdue contributions)

• Notes: Interest and penalty on overdue contributions. A compliance line, not a tax base; it exists because compulsory contributions are sometimes paid late.

• Name: Egészségügyi szolgáltatók visszafizetése (Provider Repayments)

• Current yield: 280.0 millió Ft

• Type: Charge (recovery from providers)

• Notes: Repayments by health providers — recovery of overpayments or unspent financing. A minor cost-recovery line.

• Name: Központi hivatali szerv támogatása (Administrative-Organ Operating Support)

• Current yield: 600.0 millió Ft

• Type: Other (intra-budget operating support)

• Notes: The operating support booked to the Fund’s central administrative organ — the financing-in counterpart to the organ’s operating budget. An intra-budget bookkeeping line that balances the administrative cost-centre.

• Name: Vagyongazdálkodási bevétel (Asset-Management Income)

• Current yield: 46.7 millió Ft

• Type: Other (property income)

• Notes: Income from the Fund’s managed property, against the 5.7 millió Ft asset-management cost. Minor; net positive.

Chapter Summary

Classification	Count	Total (millió Ft)
Immediate Cut	0	0.0
Phase-Out	4	908,680.8
Nominal Freeze	1	450.0
Keep	42	4,036,437.8
Total	47	4,945,568.6

Revenue	Total (millió Ft)
Total chapter revenue	4,945,568.6

The four Phase-Out lines are CSED (182,603.8 millió Ft), Táppénz (266,560.8 millió Ft), GYED (457,002.0 millió Ft), and Gyógyfürdő (2,514.2 millió Ft) — together 908,680.8 millió Ft, or 18.4% of the chapter. The three cash-benefit lines account for 906,166.6 millió Ft of that total and share a single structural defect: an earnings-scaled benefit financed from a flat-rate pooled levy. The fourth, Gyógyfürdő, follows a distinct mechanism (5-year linear, commercial substitution) and differs in character — a phase-out of a discretionary, commercially-substitutable subsidy, not a re-architecting of a social-insurance entitlement.

Year-1 saving: 502.8 millió Ft. This comes entirely from the Gyógyfürdő linear 5-year phase-out (2,514.2 / 5 = 502.8 millió Ft in year 1). The three cash-benefit Phase-Out lines produce zero year-1 saving: in the first transition year every existing entitlement is fully protected and every current contributor retains pooled cover, so the hybrid-pillars mechanism generates no net saving until funded balances begin to mature and the legacy pooled cohort begins to age out.

Key Observations

• The reform target in this chapter is a financing mechanism, not a level of spending. The Health Insurance Fund is not over-funded; Hungary spends well below the OECD average on health, per capita and as a share of GDP.¹ Of the 4,945,568.6 millió Ft envelope, 4,036,437.8 millió Ft — 81.6% — is classified Keep, because curative and emergency medicine, disability support, drug and device subsidy, and the administration of all of it are rights-relevant functions the framework affirms. The phase-out argument applies to 18.4% of the chapter, and even there it is an argument about how the benefit is financed, not about whether income protection around birth, sickness and child-rearing should exist. This is the distinction the whitepaper should carry forward: the classical-liberal objection to CSED, táppénz and GYED is not that they are too generous but that pooling a flat-rate levy to fund an earnings-scaled benefit makes lower earners cross-subsidise higher earners.

• The within-class transfer is the analytically load-bearing finding. Each of the three large cash benefits pays out in proportion to the recipient’s prior wage — CSED at 100% of prior income, GYED at 70% to a ceiling, táppénz at 60% of the contribution base — while the funding is a flat-rate levy on every insured wage. The arithmetic is the same in all three cases: a minimum-wage contributor and a ceiling-level contributor pay the same rate, and the ceiling-level contributor draws a benefit a wide multiple larger. On net, the levy transfers from lower earners to higher earners. The universalist branding — “every working parent”, “every insured worker” — is accurate about coverage and silent about distribution. The diagnostic for the pattern is constant: earnings-scaled benefit, flat-rate pooled funding, universalist framing. Where a reader’s own family includes a minimum-wage earner, the family-scale reality is direct — that earner’s contribution is part-funding the supplement that scales with an unrelated upper-decile earner’s salary.

• Disability is correctly distinguished from the earnings-replacement lines. It would be a category error to apply the funded-account argument to the rokkantsági/rehabilitációs block (419,852.3 millió Ft). A birth or a sick week is a foreseeable event a worker can insure against over a career; permanent loss of earning capacity, often early in life, is not — a worker disabled young has had no career over which to accumulate a self-insurance balance. Disability support belongs in the framework’s protective category, a response to involuntary harm whose magnitude makes it a matter of rights. The genuine governance question there is the integrity of the assessment process, not the existence of the benefit.

• More than a third of the “insurance fund” is general-revenue financed. The költségvetési hozzájárulások lines transfer roughly 1.71 ezer milliárd Ft from the central budget into the Fund — about 35% of the chapter — to cover the gap between earmarked contributions and benefit spending. The Health Insurance Fund is not a closed actuarial system; it is a pooled transfer system topped up from general taxation. That is why the regressive cross-subsidy in the earnings-scaled benefits does not self-correct, and it is also why the contribution rates understate the true tax cost of the system: the worker pays the payroll levy and, as a general taxpayer, the top-up.

• The curative block exposes a delivery-model problem the budget line cannot reach. The 2.89 ezer milliárd Ft curative-preventive envelope is classified Keep, but a single state purchaser (NEAK) paying overwhelmingly state-owned providers operates without a market price signal for the cost, mix or quality of care — tariffs are set administratively, capacity is allocated administratively, and the soft budget constraint of state-owned providers runs through the system. The visible result is the queue, and the parallel private sector that already exists in Hungary precisely because the state monopoly fails on access — roughly a quarter of total health spending is already out-of-pocket.¹ The reform direction is purchaser-provider separation, provider plurality and price discovery on routine care, but that is system-level delivery reform for the whitepaper to develop, not a line-item reclassification.

• The pharmaceutical-levy revenue is a symptom of administered pricing. The gyógyszergyártók befizetései revenue (132,440.2 millió Ft) is the state clawing back, through a sector levy, margin that its own administered drug- pricing system generates for manufacturers and distributors. The levy and the gyógyszertámogatás subsidy it partly offsets are two halves of the same administered-pricing arrangement; genuine price discovery would shrink both together. The levy is not an independent revenue base to be protected — it is a measure of how far drug pricing has been removed from the market.

Sources

Footnotes

1. Health at a Glance 2025: Hungary. OECD. 2025. https://www.oecd.org/en/publications/health-at-a-glance-2025_15a55280-en/hungary_da09a524-en.html. Hungary health spending ~6.5% of GDP and ~USD 3,303 per capita (PPP) vs OECD averages of ~9.3% of GDP and ~USD 5,967 per capita; public financing ~74% of current health spending; out-of-pocket payments ~23% of health expenditure (2023), against an EU average near 16%. ↩ ↩² ↩³ ↩⁴

2. Csecsemőgondozási díj (CSED). Magyar Államkincstár / csalad.hu. 2025. https://csalad.hu/tamogatasok/csecsemogondozasi-dij-csed. CSED is paid for 168 calendar days at 100% of daily income (70% where the parent undertakes paid work after the child’s first three months). ↩

3. A táppénzes munkanapok száma — grafikon. HR Portál. 2025. https://www.hrportal.hu/hr/a-tappenzes-munkanapok-szama-grafikon-20250816.html. In 2024 workers claimed approximately 26 million calendar days of sick benefit for their own illness, a 3% increase on the prior year. ↩

4. Chile’s Unemployment Insurance Scheme (Cuenta Individual de Cesantía, Law 19,728 of 2001). World Bank. 2003. https://documents1.worldbank.org/curated/en/262071468329399756/pdf/378040CL0Unemp1nce0SP0061201PUBLIC1.pdf. Individual unemployment savings accounts with a defined benefit floor financed from a separate solidarity fund. ↩

5. GYED 2025 — Amount, conditions, claiming and taxation. Forvis Mazars Hungary. 2025. https://www.forvismazars.com/hu/en/insights/articles/gyed-2025-amount-conditions-claiming-taxation. GYED is 70% of the parent’s prior gross income subject to a ceiling; the maximum monthly amount rose to a gross HUF 451,920 from 1 January 2026. ↩

6. Fontos változás lépett életbe, negyedmillió magyart érint. Index. 2024. https://index.hu/belfold/2024/05/30/megvaltozott-munkakepesseguek-szabalyozas-modositas-rehabilitacios-szakerto/. The 2024 change to the qualification rules for people with reduced working capacity affects approximately 254,000 people. ↩

7. NEAK — Drug Reimbursement Tiers (Data for International Price Comparisons). Nemzeti Egészségbiztosítási Alapkezelő (NEAK). 2026. https://www.neak.gov.hu/felso_menu/szakmai_oldalak/gyogyszer_segedeszkoz_gyogyfurdo_tamogatas/egeszsegugyi_vallalkozasoknak/gyartok_forgalomba_hozok/dipc. NEAK reimburses prescription medicines at tiered rates depending on therapeutic category and severity of indication, with higher state-paid shares attaching to more chronic and severe conditions. ↩

8. Tax and contribution rates — Hungary. Forvis Mazars / KPMG Hungary tax summary. 2025. https://www.forvismazars.com/hu/en. The employee social-insurance contribution (társadalombiztosítási járulék) is levied at 18.5% of gross wages. ↩

9. Szociális hozzájárulási adó (Social Contribution Tax). Nemzeti Adó- és Vámhivatal (NAV). 2025. https://nav.gov.hu. The szociális hozzájárulási adó is an employer-side payroll tax levied at 13% of gross wages. ↩